ATE157870T1 - Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma - Google Patents

Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma

Info

Publication number
ATE157870T1
ATE157870T1 AT95100934T AT95100934T ATE157870T1 AT E157870 T1 ATE157870 T1 AT E157870T1 AT 95100934 T AT95100934 T AT 95100934T AT 95100934 T AT95100934 T AT 95100934T AT E157870 T1 ATE157870 T1 AT E157870T1
Authority
AT
Austria
Prior art keywords
optionally substituted
hydrogen
treatment
ophthalmic composition
benzoxathiepine
Prior art date
Application number
AT95100934T
Other languages
German (de)
English (en)
Inventor
Takahiro Ogawa
Takaaki Deguchi
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE157870T1 publication Critical patent/ATE157870T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95100934T 1994-01-27 1995-01-25 Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma ATE157870T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP747094 1994-01-27

Publications (1)

Publication Number Publication Date
ATE157870T1 true ATE157870T1 (de) 1997-09-15

Family

ID=11666688

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95100934T ATE157870T1 (de) 1994-01-27 1995-01-25 Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma

Country Status (9)

Country Link
US (1) US5538974A (https=)
EP (1) EP0667156B1 (https=)
KR (1) KR950032169A (https=)
CN (1) CN1116928A (https=)
AT (1) ATE157870T1 (https=)
CA (1) CA2141176A1 (https=)
DE (1) DE69500660T2 (https=)
ES (1) ES2106573T3 (https=)
TW (1) TW316235B (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
CN1269484C (zh) 1998-09-18 2006-08-16 艾尔科实验室公司 用于治疗青光眼的5-羟色胺激活性激动剂
US6903081B2 (en) * 2000-03-31 2005-06-07 Purdue Research Foundation Phosphoramidates and methods therefor
FR2822467B1 (fr) * 2001-03-22 2003-12-12 Pf Medicament Derives benzoxathiepines et leur utilisation comme medicaments
WO2003051352A1 (en) * 2001-12-14 2003-06-26 Alcon, Inc. Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
TW593302B (en) * 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
PT1534391E (pt) * 2002-07-19 2007-05-31 Biovitrum Ab Novos derivados e piperazinilo-pirazinona para o tratamento de desordens relacionadas com o receptor 5-ht
JP2006501245A (ja) * 2002-08-30 2006-01-12 アルコン,インコーポレイテッド 置換された5−クロマン−5−イル−エチルアミン化合物および緑内障の治療のためのその使用
BR0316775A (pt) * 2002-12-13 2005-11-01 Alcon Inc Novos análogos de benzopirano e seu uso para o tratamento de glaucoma
CA2536185C (en) * 2003-08-20 2012-06-26 Santen Pharmaceutical Co., Ltd. Drug delivery system by administrating fine particles to sub-tenon
US7476687B2 (en) * 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
TW200520760A (en) * 2003-12-15 2005-07-01 Alcon Inc Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
US7129257B1 (en) * 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
US20050276867A1 (en) 2004-06-09 2005-12-15 Allergan, Inc. Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative
US7425572B2 (en) * 2004-12-08 2008-09-16 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
TW200744567A (en) * 2005-09-23 2007-12-16 Alcon Inc Phenylethylamine analogs and their use for treating glaucoma
US20070293475A1 (en) * 2006-06-20 2007-12-20 Alcon Manufacturing Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
EP2119436A4 (en) 2006-10-20 2010-03-03 Ltd Liability Company Mitotech PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF EYE DISEASES
WO2008048135A1 (fr) * 2006-10-20 2008-04-24 Limited Liability Company 'mitotechnology' Composition destinée à la régénération, la stimulation de la croissance et l'adaptation de plantes à tous types de facteurs de stress
US8349902B2 (en) 2007-01-29 2013-01-08 Mitotech Sa Pharmaceutical compositions useful for preventing and treating oncological diseases
EP2145623A4 (en) * 2007-01-29 2010-10-27 Ltd Liability Company Mitotech PHARMACEUTICAL AND COSMETIC COMPOSITIONS FOR ACCELERATING THE PROCESS OF WOUND HEALING AND OTHER SURFACE INJURIES
US8679557B2 (en) * 2007-02-27 2014-03-25 Sentiss Pharma Private Limited Synergistic herbal ophthalmic formulation for lowering the intra ocular pressure in case of glaucoma
US9439916B2 (en) * 2007-04-11 2016-09-13 Mitotech Sa Composition for decelerating the aging in the organism and for extending the life time thereof and the use of said composition
US8518915B2 (en) 2007-06-29 2013-08-27 Mitotech Sa Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases
WO2010056145A1 (ru) 2008-11-12 2010-05-20 Общество С Ограниченной Ответственностью "Митотехнология" Способ умеренного повышения протонной проводимости биологических мембран при помощи митохондриально- адресованных делокализованных катионов
CN102548548B (zh) * 2009-06-10 2017-09-01 米拓科技有限公司(卢森堡) 用于医学和兽医学的眼科药物组合物
MX2012005356A (es) 2009-11-13 2013-01-29 Obschestvo S Ogranichennoi Otvetstvennostyu Mitotekh Substancias farmaceuticas basadas en antioxidantes dirigidos a mitocondria.
US9320690B2 (en) 2010-12-20 2016-04-26 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier
WO2012167236A1 (en) 2011-06-03 2012-12-06 Mitotech Sa Oral formulations of mitochondrially-targeted antioxidants and their preparation and use
CN112439071B (zh) * 2019-09-04 2022-05-20 武汉科福新药有限责任公司 透皮促渗组合物及其在噻吗洛尔制剂中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK166779B1 (da) * 1983-12-14 1993-07-12 Takeda Chemical Industries Ltd 1,5-benzoxatiepinderivater eller farmaceutisk acceptable salte deraf, samt farmaceutisk praeparat indeholdende en saadan forbindelse
EP0229467A1 (en) * 1985-12-10 1987-07-22 Takeda Chemical Industries, Ltd. 1,5-Benzoxathiepin derivatives, their production and use

Also Published As

Publication number Publication date
EP0667156B1 (en) 1997-09-10
US5538974A (en) 1996-07-23
EP0667156A1 (en) 1995-08-16
CA2141176A1 (en) 1995-07-28
KR950032169A (ko) 1995-12-20
TW316235B (https=) 1997-09-21
DE69500660D1 (de) 1997-10-16
CN1116928A (zh) 1996-02-21
DE69500660T2 (de) 1998-02-26
ES2106573T3 (es) 1997-11-01

Similar Documents

Publication Publication Date Title
ATE157870T1 (de) Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma
DE19680619D2 (de) Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
ATE225770T1 (de) Difluoroprostaglandin-derivate und ihre anwendung
ZW6991A1 (en) Heterocyclene derivatives
ATE112762T1 (de) Herstellung und verwendung von n-jodopropargyl- oxycarbonylaminosäure-estern als antimicrobielle mittel.
ATE161723T1 (de) Arzneimittel zur verwendung bei der behandlung von parkinsonismus
DE69406323D1 (de) Substituierte Aminsäure Derivate verwendbar für die Behandlung von Arteriosclerosis
DE69326395D1 (de) Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ATE104965T1 (de) Chinolinderivate, ihre herstellung und verwendung.
ATE284684T1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ATE196080T1 (de) Verwendung von diphenylethanderivaten zur herstellung eines arzneimittels zur behandlung von glaukom
DE69611502D1 (de) (Oxo-1-Alkyl)amino-2-desoxy-2-glucopyranosid von Dihydroxy-2,3-propyl, Verfahren zur Herstellung und ihre Verwendungen
DE69706355D1 (de) Alkylendiamin-Derivate als Arzneimittel zur Behandlung von Geschwüren und Hemmung von Helicobacter pylori
EP0635011A1 (en) HYDRAZIDE DERIVATIVES OF 3,4-DIHYDRO-2H-1-BENZOPYRANES.
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE122892T1 (de) Zusammensetzung gegen katarakt.
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
ATE120461T1 (de) Imidazolylpropylguanidinderivat, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel.
ATE157874T1 (de) Mittel zur verbesserung der peripheren durchblutung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties